TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase
September 18 2023 - 4:05PM
TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical
technology company focused on providing innovative soft-tissue
reconstruction solutions that optimize clinical outcomes by
prioritizing the preservation and restoration of the patient's own
anatomy, today announced that the Company will participate in the
Gilmartin Group Emerging Growth Company Showcase.
TELA’s management is scheduled to present at the
Gilmartin Group Emerging Growth Company Showcase at 9:30 am ET on
September 21st, 2023. Interested parties can access the live and
archived webcast at ir.telabio.com.
About TELA Bio, Inc.TELA Bio,
Inc. (NASDAQ: TELA) is a commercial-stage medical technology
company focused on providing innovative technologies that optimize
clinical outcomes by prioritizing the preservation and restoration
of the patient's own anatomy. The Company is committed to providing
surgeons with advanced, economically effective soft-tissue
reconstruction solutions that leverage the patient's natural
healing response while minimizing long-term exposure to permanent
synthetic materials. For more information, visit
www.telabio.com.
Investor ContactGreg
Chodaczek347-620-7010ir@telabio.com
TELA Bio (NASDAQ:TELA)
Historical Stock Chart
From Apr 2024 to May 2024
TELA Bio (NASDAQ:TELA)
Historical Stock Chart
From May 2023 to May 2024